Article

2 Iconography
Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates



Journal of the American Academy of Dermatology
Sous presse. Epreuves corrigées par l'auteur. Disponible en ligne depuis le vendredi 29 novembre 2019
Doi : 10.1016/j.jaad.2019.02.029
Systemic timolol exposure following topical application to infantile hemangiomas
 

Beth A. Drolet, MD a, , Felix Boakye-Agyeman, MD b, Barrie Harper, BSMT (ASCP), PMP b, Kristen Holland, MD a, Andrew Lewandowski, PhD c, Nicole Stefanko, MD a, Chiara Melloni, MD, MHS b
on behalf of the

Pediatric Trials Network Steering Committee (See Acknowledgments for a listing of committee members.)

Gary Furda, Danny Benjamin, Edmund Capparelli, Gregory L. Kearns, Ian M. Paul, Christoph Hornik, Kelly Wade

a Medical College of Wisconsin, Milwaukee, Wisconsin 
b Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina 
c The Emmes Corporation, Rockville, Maryland 

Correspondence to: Beth A. Drolet, MD, University of Wisconsin, The School of Medicine and Public Health.University of WisconsinThe School of Medicine and Public Health

 Funding sources: Supported under National Institute of Child Health and Human Development contract HHSN275201000003I for the Pediatric Trials Network (principal investigator, Danny Benjamin). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
 Disclosure: Dr Drolet reports an investigator-initiated trial examining the safety of oral propranolol for treatment of infantile hemangioma that was sponsored by Pierre Fabre. She is owner and co-founder of Peds Derm Development Group, LLC. Dr Boakye-Agyeman, Mr Harper, Dr Holland, Dr Lewandowski, and Dr Stefanko have no conflicts of interest to disclose.


Top of the page

© 2019  American Academy of Dermatology, Inc.@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline
You can move this window by clicking on the headline
@@#110903@@